BlackRock Health Sciences TrustBME
About: Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
100% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 3
4% more funds holding
Funds holding: 67 [Q2] → 70 (+3) [Q3]
0% more funds holding in top 10
Funds holding in top 10: 1 [Q2] → 1 (+0) [Q3]
2.23% less ownership
Funds ownership: 25.34% [Q2] → 23.12% (-2.23%) [Q3]
7% less capital invested
Capital invested by funds: $144M [Q2] → $134M (-$10.1M) [Q3]
39% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 31
Research analyst outlook
We haven’t received any recent analyst ratings for BME.
Financial journalist opinion
Based on 4 articles about BME published over the past 30 days